Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Cancer Immunol Res. 2016 Oct 31;4(12):1007–1015. doi: 10.1158/2326-6066.CIR-16-0156

Table 2.

Top 6 in silico predicted H-2Db and H-2Kb candidate SMA-560-derived neoantigens with the corresponding amino acid sequence. The mutated amino acid is denoted by bold and underlining.

H-2Db Restriction

Amino acid mutation Neoantigen sequence
mOdc1 Q129L YAASNGVLM
mDock11 G1958V SVQVNAVPL
mPlekhg6 G10C FGPPNECPL
mAtp11b K884M FFYMNVCFI
mNcapd3 V510L NTVLNPSPL
mIfit2 V60I ATMCNILAYI

H-2Kb Restriction

Amino acid mutation Neoantigen sequence

mENSMUSG00000074999 C15F SSFIYAYI
mLama5 G897V VRFVFNPL
mE2f8 K272R MSQRFVML
mAtp11b K884M VQYFFYMNV
mMertk R682P TFLLYSPL
mStt3b G323V AAVVFALL